Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT

Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Mar 10, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how a special pill containing healthy gut bacteria might help people living with HIV who drink heavily. Researchers believe that heavy drinking can change the balance of bacteria in the gut, which may increase the risk of heart disease and early death. By giving participants this pill, the trial aims to see if it can boost the good bacteria in their gut, reduce inflammation, and ultimately lower the chances of developing heart problems.

To be eligible for this study, participants need to be living with HIV and aged between 18 and 65 years old. The trial is currently looking for volunteers, and it is open to all genders. Participants will take the pill as part of the study and will be monitored to see how it affects their health. It's important to note that participants need to be fluent in English to join. This trial could provide valuable insights into improving heart health for people with HIV who drink alcohol.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • HIV infected
• Exclusion Criteria:
• • Not fluent in English